ArticleFrontiers in oncology2026

Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma.

Zijuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.